<dhhead-MANAGEMENT DISCUSSION AND ANALYSTS REPORT</dhhead-
In compliance of the provisions of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations 2015"), Please find Management Discussion and Analysis Report for the year 2025-26, forming part of Annual Report.
1. INDUSTRY STRUCTURE & DEVELOPMENTS
Company recognizes operations as an important source of competitive advantage and further believes in continually striving for higher and better levels of quality not just in its products, but also in its operations, without losing sight of its commitments towards the environment and communities where it operates. A host of initiatives are continually rolled out by the company to improve productivity while reducing its energy usage.
Company is committed to create an open and transparent organization that is focused on people and their capability, and fostering an environment that enables them to deliver superior performance. Company continued to focus on expanding its product offerings to consumers by way of new product launches and expansion of existing products, thereby continuing to address the growing and ever changing needs of its consumers.
Health care has been identified as an important growth engine for the future. Your Company is lining up a host of new initiatives for the same in Ayurveda and range of Ayurveda Based ethical and Classical and Health care products.
2. OPPORTUNITIES AND THREATS
The consumer landscape has been continuously evolving and one has to keep pace with the
changing trends in order to win consumer confidence. The Herbal Wave in India offers a significant
growth opportunity to be tapped and appropriate strategies need to be formulated to capture
this opportunity. Desh Rakshak Aushdhalaya Limited is capturing these opportunities by investing in brands that are positioned strongly on the herbal platform and appeal to the
contemporary consumers. Desh Rakshak Aushdhalaya Limited is leveraging its deep experience
and heritage in the field of Ayurveda and building its business based on the Health and
Wellness theme across categories. Currency volatility, slowdown in category growth rates and unpredictable weather patterns are some of the threats to the companys prospects.
3. SEGMENT-WISE/ PRODUCT-WISE PERFORMANCE
Products ranging from AmalkiChurna, Ashwagandha Tablet, TriphalaChurna, LavanaBhaskarChurna, Sat Shilajeet, ShunthiChurna, HingwadiChurna, GasharVati, BuddhivardhakYog, Balamrit, LodhraChurna,
Narayan Chuma, GangadharChuma, MustakaChuma, ShatavariChuma Tablet, Ashwagandha Tab, LavangadiChuma, ShringyadiChurna, ShatavaryadiChurna, MulethiChurna Tab., DantMohiniManjan, GokshurChurna, BhringrajChurna, MulethiChurna, DashmoolKwath, PunarnavastakKwath, SomkalpChurnaVachChurna, AshwagandhaLehyaBansavaleha, Chyavanprash Special,
ChyavanprashVishesh, GiloySatva, HaridraKhanda, BrahmiGharit, TrifalaGharit, NeemTaila, JatyadiTailaDashmoolTaila, DhanvantaraTaila are products which are famous amongst the consumers. The list is far-reaching and faster consumption of all types of rasRasayan, Churna, Avaleha-Pak, Kwath Churn, Bhasma-Pisti, Guggul ,LouMandoor, Parpati , KupipakwaRasayan, Asava-Rishta, AushadhiTaila , Avaleha- Pak, Kshar-Satva making the Companys Products Competitive and best in the Ayurvedic Industry.
With a portfolio of Ayurvedic and natural products, nature and herbs are the key to our existence and company continues to invest in Research & development in order to establish beyond the boundaries of Uttarakhand.
Company has a wide range of ethical healthcare products based upon the age-old system of Ayurveda. It has a wide range of ethical medicines that are derived from herbs and form part of this holistic healthcare system, focusing on all-round well-being. The range was promoted aggressively through focused activities. This centre seeks to promote Ayurveda among the urban Indians, besides enhance availability and visibility of Ayurvedic medicines
4. OUTLOOK
An improvement in the macro-economic fundamentals is expected to ramp up demand by
improving the overall consumer sentiment. The Company expects demand to pick up as
and when the disposable income in the hands of consumers increases due to pick up in economic activity and various government initiatives like NREGA, 7th Pay commission,
implementation of DBT schemes etc .The company has a good product pipeline and has also been investing in various distribution channels to service the demand all across geographies. We are well poised to effectively capture the growth opportunities in the FMCG domain.
5. RISKS AND CONCERNS
The market for our products is highly competitive on account of both the organized and unorganized players. Players in this industry generally compete with each other on key attributes such as technical competence, quality of products, brand image, distribution network, pricing and timely delivery. The unorganized sector offers their products at highly competitive prices which may not be matched by our companys product price and consequently affect our companys volume of sales and growth prospects. Growing competition may result in a decline in our companys market share and may affect our companys margins which may adversely affect our companys business operations and our companys financial condition.
Global economic, political and social factors that are beyond our companys control could directly affect our companys performance. These factors include interest rates, rates of economic growth, fiscal and monetary policies of governments, inflation, deflation, consumer credit availability, fluctuations in commodities
markets, consumer debt levels, unemployment trends and other matters that influence consumer confidence, spending and tourism. A slowdown in economic growth in India could adversely impact our companys business. Our companys performance and the growth of our companys business are dependent on the performance of the overall Indian economy.
Increased inflation can contribute to an increase in interest rates and increased costs to our companys business, including increased costs of transportation, wages, raw materials and other expenses relevant to our companys business. Any increase in inflation in India can increase our Companys expenses and may adversely affect our companys business, cash flow, results of operations, and financial condition.
The Company is well aware of these risks and challenges and has put in place mechanisms to ensure that they are managed and mitigated with adequate timely actions. One of the key risks faced by the Company in todays scenario is the continued inflationary trend which is not only increasing cost pressures, but may also lead to demand compression for its products. Increase of imitation/fake products and brands can hamper our growth. The input Cost Pressures were managed effectively and the Company did not take any significant price increases during the year. Growth rates across quarters have been consistent and reflect your companys sound business strategies and strong execution capabilities. A slowdown in overall economic growth can lead to pressure on disposable incomes and spending power of people.
To overcome the hurdles posed by a challenging external environment, Company has been taking proactive measures in portfolio, product and channel optimization. The focus of the Company is on ensuring deeper penetration and more effective distribution of products. Company is committed to its motto of being dedicated to the health and well-being of every household. With a legacy and experience, company is today trusted healthcare brand and Ayurvedic and Natural Health Care Company.
The Company increased its efforts to improve productivity by deploying various cost reduction and energy saving initiatives, resulting in a reduction in manufacturing costs to lower levels.
6. INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has a proper and adequate system of internal control including internal financial controls. Your Company has an Audit Committee headed by a non-executive independent director, inter-alia, to oversee your Companys financial reporting process, disclosure of financial information, and reviewing the performance of statutory and internal auditors with management. The internal control system, including internal financial controls of the Company, is monitored by an independent internal audit team, which encompasses examination/ periodic reviews to ascertain adequacy of internal controls and compliance to Companys policies. Weaknesses noted along with agreed upon action plans are shared with audit committee, which ensures orderly and efficient conduct of the business and effectiveness of the system of internal control. The audit function also looks into related party transactions, preventive controls, investigations, as well as other areas requiring mandatory review per applicable laws. The powers of the Audit Committee, inter-alia, include seeking information from any employee, obtaining outside legal or other professional advice, and investigating any activity of the Company within the committees term of reference. Your Companys internal audit department verifies the information of the financial statements as well as the compliance with your Companys policies to maintain accountability and ensuring controls are in place to safeguard of all its assets and correctness of accounting records. The internal audit department
shares regular updates regarding the work done, coverage, weaknesses noted and other relevant issues with appropriate management levels including Audit Committee. Observations/ weaknesses noted from time to time are suitably acted upon and followed up at different levels of management. The internal control is supplemented by an extensive program of audits and periodic review by the management.
7. DISCUSSION ON FINANCIAL PERFORMANCE WITH RESPECT TO OPERATIONAL PERFORMANCE
During the year under review, the turnover of the Company is Rs. 7,10,44,312 in comparison with the last years Rs 6,27,06,600. The profit after tax of the company is Rs 56,21,600. Despite high inflationary and cost pressures throughout the year, company capitalized on every available opportunity and undertook strategic initiatives coupled with to exploit the full industry potential, besides making efforts towards cost reduction and improved efficiency which enable the company to grow reasonably well.
In continuation of its efforts towards offering innovative, more effective and value added products to the consumers for providing them with value for money. Company continued combining traditional Ayurvedic Science with adoption of the modern manufacturing technology.
8. HUMAN RESOURCES AND INDUSTRIAL RELATIONS
Humankind is the Greatest Resource
The Companys endeavour has always been to build an organization where its people are always engaged and empowered to do their best. The Companys culture is focused on customer-centricity collaborative team work, result orientation, entrepreneurial mindset and developing people.
Owing to the competitiveness and diversity of Indian markets, the Company strives to ensure adequate succession planning of its leadership talent pool. In line with the Companys focus on employee empowerment, it has also designed new Ways of Working to deliver high operational excellence and governance.
To remain competitive, improving employee productivity is of utmost importance to the organization and the company strive to achieve benchmark performance in this area. During Financial Year 2025-26, the overall Employee Productivity for the Company increased.
The Company recognizes and appreciates the contribution of all its employees in its growth path. Our Company strives to retain talent by facilitating career growth through job enrichment and empowerment, as it believes that the pool of the human resource is the biggest asset of the organization. Your Company maintains a cordial relationship with its employees through a constructive work environment in support of productive gains. There are 18 employees in the Company.
9.KEY FINANCIAL RATIOS/ACCOUNTING RATIOS
Following are important ratios comparing performance of financial year ended on 31.03.2026 and financial year ended on 31.03.2025:
| Ratio Analysis | |||||||
| Particulars | Formula | Calculation 25-26 | Ratio | Calculation 24-25 | Ratio | Reasons | |
| 1.00 | Current Ratio | Current Assets | 108,542,000.00 | 2.49 | 79,740,152.00 | 1.61 | The current ratio compares all of a companys current assets to its current liabilities. An increasing current ratio is caused by an |
| Current Liabilities | 43,583,512.00 | 49,388,826.00 | |||||
| 2.00 | Debt Equity Ratio | Debt | 32,406,754.00 | 0.24 | 30,820,107.00 | 0.31 | Decline is on account of a higher equity base following the preferential allotment coupled with a reduction in long-term borrowings during the year. |
| Equity | 132,893,635.00 | 99,552,035.00 | |||||
| 3.00 | Return On Equity | Profit after tax | 5,621,600.00 | 0.04 | 4,766,244.00 | 0.05 | Broadly stable; the enlarged equity base (due to the mid-year preferential allotment) offset the increase in absolute profitability, keeping ROE in a similar range. |
| Total Equity | 132,893,635.00 | 99,552,035.00 | |||||
| 4.00 | Inventory Turnover | Cost of Goods Sold (COGS) | 29,833,204.00 | 13.30 | 25,676,903.00 | 10.38 | Increase is due to higher consumption of materials in line with growth in production/sales, while average inventory holding remained comparatively low, reflecting faster inventory rotation. |
| Average Inventory | 2,243,522.50 | 2,473,113.50 | |||||
| 5.00 | Trade Receivable Turnover | Credit Sales | 71,044,312.00 | 0.86 | 62,706,562.00 | 0.85 | Increase in Trade Receivables Ratio generally means the company is collecting its receivables faster. |
| Average Trade Receivable | 82,659,633.50 | 73,546,672.00 | |||||
| 6.00 | Debt Service Coverage Ratio | EBDITA | 13,955,687.00 | 0.45 | 12,788,282.00 | 0.38 | Increase in Debt Service Coverage Ratio due to Increase in operating profit |
| Principle + Interest | 30,842,816.00 | 33,285,053.00 | |||||
| 7.00 | Trade Payable Turnover Ratio | Credit Purchase | 28,774,231.00 | 0.66 | 22,599,725.00 | 0.54 | Increase in trade payable turnover ratio due to Faster payment to suppliers |
| Average Trade Payable | 43,759,563.00 | 41,687,994.50 | |||||
| 8.00 | Net Capital Turnover Ratio or Net Assets Turnover Ratio | Sales/COGS | 71,044,312.00 | 0.53 | 62,706,562.00 | 0.63 | Decrease in Net Capital Turnover Ratio due to Increase in inventory and Increase in cash and bank balances |
| Net Assets | 132,893,635.00 | 99,552,035.00 | |||||
| 9.00 | Net Profit Ratio | Net Profit | 5,621,600.00 | 0.08 | 4,766,244.00 | 0.08 | No Change |
| Sales | 71,044,312.00 | 62,706,562.00 | |||||
| 10.00 | Return On Capital Employed | EBIT | 8,461,458.00 | 0.05 | 8,926,258.00 | 0.07 | Decline reflects capital employed (equity + debt) growing faster than operating profit, largely due to the mid-year equity infusion via preferential allotment |
| Capital Employed | 163,713,742.00 | 130,372,142.00 | |||||
| 11.00 | Return On Investment | Net Profit | 5,621,600.00 | 1.28 | 4,766,244.00 | 1.59 | Decrease in Return On Investment due to Increase in working capital |
| Total Investment | 4,394,424.00 | 3,001,296.00 | |||||
| 12.00 | Debtor Turnover Ratio | Debtor | 91,772,595.00 | 1.29 | 73,546,672.00 | 1.17 | Increase in Debtor Turnover Ratio due to Faster collection from customers |
| Sales | 71,044,312.00 | 63,038,579.00 | |||||
| 13.00 | Interest Coverage Ratio | EBDITA | 13,955,687.00 | 4.91 | 12,788,282.00 | 4.29 | The interest coverage ratio (ICR) measures a companys ability to handle its outstanding debt. Increase in Interest Coverage ration due to Increase in operating profit |
| Interest | 2,839,858.00 | 2,981,059.00 | |||||
| 14.00 | Return On Net Worth | Net Income | 5,621,600.00 | 0.04 | 4,766,244.00 | 0.05 | Return on Equity decline due to Increase in shareholders equity |
| Shareholders Equity | 132,893,635.00 | 99,552,035.00 | |||||
| 15.00 | Operating Profit Margin | Operating Margin | 8,461,458.00 | 0.12 | 8,926,258.00 | 0.14 | Decrease in Operating Margin due to Increase in raw material prices and high competition |
| Revenue | 71,044,312.00 | 63,038,579.00 | |||||
10. CAUTIONARY STATEMENT
Statements in this Management Discussion and Analysis Report describing the Desh Rakshak Aushdhalaya Limited objectives, projections, estimates and expectations might be construed as forward looking statements within the meaning of applicable laws and regulations.
Actual results may differ substantially or materially from those expressed or implied. Important developments that could affect the Companys operations include a downward trend in the FMCG industry, rise in input costs, exchange rate fluctuations and significant changes in political and economic environment, environment standards, tax laws, litigation and labour relations.
To ensure our Long term corporate success, company implements risk management system which includes recording, monitoring and controlling internal enterprise business risks and addressing them through informed and objective strategies.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.